GlassScriptPhysician profile
Danielle Garten
NPI 1215576962
$1,626.71
in general payments reported to CMS, 2019-2025
22 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.19 · 2022: $290 · 2023: $485 · 2024: $513 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $294.09 | 2023-2025 | |
| Astellas Pharma US INC | $156.49 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $146.87 | 2021-2024 | Slynd |
| Evofem Biosciences, INC. | $133.67 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $102.92 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $83.59 | 2023-2025 | Accrufer |
| Pfizer INC. | $82.29 | 2022-2025 | |
| Exact Sciences Corporation | $79.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $75.21 | 2021-2023 | Nexplanon |
| Abbvie INC. | $73.83 | 2023-2024 | |
| Avion Pharmaceuticals | $68.58 | 2022-2023 | Balcoltra |
| Biogen, INC. | $59.29 | 2024-2025 | Zurzuvae |
| Mylan Pharmaceuticals INC. | $49.44 | 2021-2022 | |
| Myovant Sciences INC. | $38.66 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $35.80 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $28.94 | 2022 | |
| Daiichi Sankyo INC. | $27.65 | 2023 | Injectafer |
| Novo Nordisk INC | $20.87 | 2023 | Wegovy |
| Hologic Sales and Service, LLC | $18.55 | 2025 | Aptima, Thinprep 2000 Processor |
| Mission Pharmacal Company | $18.51 | 2023 | Citranatal |
| Bayer Healthcare Pharmaceuticals INC. | $18.06 | 2025 | |
| Millicent US INC | $13.65 | 2025 | Femlyv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Garten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.